Prof. Dr. Leman YALÇINTEPE GÜNEŞTUTAR

Makaleler 16

1. Iron alters Ca2+ homeostasis in doxorubicin-resistant K562 cells

Yalcintepe L., Erdag D., AKBAŞ F., Kucukkaya B.

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY , cilt.47, sa.7, ss.1221-1230, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

2. Calcium homeostasis in cisplatin resistant epithelial ovarian cancer.

Kucukkaya B., Basoglu H., Erdag D., AKBAŞ F., SÜSGÜN S., Yalcintepe L.

General physiology and biophysics , cilt.38, sa.4, ss.353-363, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

3. Kanser Hücrelerinde Hücre İçi Kalsiyum Hareketlerinin Bileşenleri

YALÇINTEPE GÜNEŞTUTAR L.

Turkiye Klinikleri J Med Sci , cilt.37, sa.2, ss.98-108, 2017 (Scopus) Sürdürülebilir Kalkınma

4. Effect of CD38 on the multidrug resistance of human chronic myelogenous leukemia K562 cells to doxorubicin.

Yalcintepe L., Halis E., Ulku S.

Oncology letters , cilt.11, sa.3, ss.2290-2296, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

5. Modulation of iron metabolism by iron chelation regulates intracellular calcium and increases sensitivity to doxorubicin

Yalcintepe L., Halis E.

BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES , cilt.16, sa.1, ss.14-20, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

6. Characterization of Lin(-)ALDH(bright) population using Ehrlich ascites tumor cells in mice

Yalcintepe L., Altinel P., Albeniz I., Yilmaz A., Nurten R.

TUMOR BIOLOGY , cilt.35, sa.10, ss.10363-10373, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

7. Elektroforezde Yeni Yaklaşımlar

GÜNEŞTUTAR L.

Sigma (YTU, Mühendislik ve Fen Bilimleri Dergisi) , cilt.27, sa.2, ss.151-160, 2009 (Hakemli Dergi)

8. Erythrocyte CD38 as a prognostic marker in cancer

Albeniz I., Demir O., Tuerker-Sener L., Yalçıntepe L., Nurten R., Bermek E.

HEMATOLOGY , cilt.12, sa.5, ss.409-414, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

9. Expression of interleukin-3 receptor subunits on defined subpopulations of acute myeloid leukemia blasts predicts the cytotoxicity of diphtheria toxin interleukin-3 fusion protein against malignant progenitors that engraft in immunodeficient mice.

Yalcintepe L., Frankel A., Hogge D.

Blood , cilt.108, sa.10, ss.3530-7, 2006 (SCI-Expanded)

10. Nitric oxide levels during erythroid differentiation in K562 cell line.

Kucukkaya B., Ozturk G., Yalcintepe L.

Indian journal of biochemistry & biophysics , cilt.43, sa.4, ss.251-3, 2006 (SCI-Expanded)

11. Variant diphtheria toxin-interleukin-3 fusion proteins with increased receptor affinity have enhanced cytotoxicity against acute myeloid leukemia progenitors.

Hogge D., Yalcintepe L., Wong S., Gerhard B., Frankel A.

Clinical cancer research : an official journal of the American Association for Cancer Research , cilt.12, sa.4, ss.1284-91, 2006 (SCI-Expanded)

12. Changes in metabolism NAD/ADP-ribose in rectal cancer

Yalcintepe L., Turker-Sener L., Sener A., Yetkin G., Tiryaki D., Bermek E.

BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH , cilt.38, sa.3, ss.361-365, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma

13. Nuclear CD38 in retinoic acid-induced HL-60 cells.

Yalcintepe L., Albeniz I., Adin-Cinar S., Tiryaki D., Bermek E., Graeff R., et al.

Experimental cell research , cilt.303, sa.1, ss.14-21, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma

14. Hemin-dependent induction and internalization of CD38 in K562 cells.

Yalcintepe L., Ercelen S., Adin-Cinar S., Badur S., Tiryaki D., Bermek E.

Journal of cellular biochemistry , cilt.90, sa.2, ss.379-86, 2003 (SCI-Expanded) Sürdürülebilir Kalkınma

15. Serum proteins with NAD+ glycohydrolase activity and anti-CD38 reactivity--elevated levels in serum of tumour patients.

Korkut C., Yalcintepe L., Kiremit-Korkut N., Uzun-Altinoz S., Issever S., Gumusel F., et al.

Cancer letters , cilt.126, sa.1, ss.105-9, 1998 (SCI-Expanded) Sürdürülebilir Kalkınma

16. Wortmannin is a potent inhibitor of DNA double strand break but not single strand break repair in Chinese hamster ovary cells.

Boulton S., Kyle S., Yalçintepe L., Durkacz B.

Carcinogenesis , cilt.17, sa.11, ss.2285-90, 1996 (SCI-Expanded)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 4

1. NAD Metabolism in Breast Cancer

GÜNEŞTUTAR L.

Febs Journal, Budapeşte, Macaristan, 3 - 07 Temmuz 2005, ss.272 Sürdürülebilir Kalkınma

2. The use of mouse models of normal and malignant hematopoiesis to design strategies for selective purging of primitive AML progenitor.

GÜNEŞTUTAR L.

Tandem BMT, Biology of Blood and Marrow Transplantation, Keystone,Colorado, Amerika Birleşik Devletleri, 10 - 14 Şubat 2005, ss.105, (Tam Metin Bildiri)

3. The use of mouse models of normal and malignant hematopoiesis to design strategies for selective purging of primitive acute myeloid leukemia (AML) progenitors

Hogge D., Wong S., YALÇINTEPE GÜNEŞTUTAR L., Frankel A.

Joint Meeting of the American-Society-for-Blood-and-Marrow-Transplantation/Center-for-International-Blood-and-Marrow-Transplant-Research, Colorado, Amerika Birleşik Devletleri, 10 - 14 Şubat 2005, cilt.11, ss.60, (Özet Bildiri)